MEDSIR, a Spain-based international company specialised in the strategic design of clinical trials, announced on Thursday that it has named Jyoti Mundra, PhD as its new chief business officer.
In the new role, Dr Mundra is to provide support in expediting the company's growth while improving its presence and business in North America. She will be heading a global business and marketing team to provide clinical solutions to biopharma companies and build a network with hospitals and institutions.
Dr Mundra has served at various full service CRO's, supporting biopharma companies to advance their drug pipeline. She has held the position of a director of Business Development at Sinclair Research. She also served in similar roles at Champions Oncology and Covance.
Asha Therapeutics chosen as BLUE KNIGHT company
Seagen and Astellas Pharma report positive outcomes in advanced bladder cancer trial
Accent Therapeutics announces executive appointments
BeiGene regains full rights to anti-PD-1 antibody TEVIMBRA (tislelizumab) from Novartis
Cizzle and Bio-Techne conclude evaluation program for CIZ1B detection
Lantern Pharma gains FDA IND clearance for LP-284 to treat non-Hodgkin's lymphoma
Accuray launches global training center at Madison HQ for advanced radiotherapy education
Cantargia AB secures USD1.1m US grant for nadunolimab leukaemia clinical trial